Adjunctive dexamethasone in adults with meningococcal meningitis

201280 citationsJournal Article

Authors

S.G.B. Heckenberg

Matthijs C. Brouwer

Arie van der Ende

Diederik van de Beek

M.J. Wennekes

RAJ Esselink · Amphia Ziekenhuis

Rutger de Graaf · Medisch Centrum Alkmaar

R. ten Houten · Ziekenhuis Groep Twente

JC Baart · Haga Hospital

Abstract

This study provides Class III evidence that adjuvant dexamethasone in adults with meningococcal meningitis does not increase negative outcomes such as deafness, death, or negative Glasgow Outcome Scale measures.

Topics & Keywords

Bacterial Infections and Vaccines Pneumonia and Respiratory Infections Immune Response and Inflammation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology

Volume 79, Issue 15, pp. 1563-1569

DOI: 10.1212/wnl.0b013e31826e2684

Field-Weighted Citation Impact: 5.15